Tata Chemicals Posts ₹3,438 Cr Q4 Revenue, Recommends ₹11 Dividend Amid Global Soda Ash Headwinds

• Consolidated revenue from operations for the quarter ended March 31, 2026 at ₹ 3,438 Cr and EBITDA at ₹ 274 Cr
• Mithapur facility (India) achieved production of 1 MTPA of Soda Ash in FY26
• Board recommends dividend of ₹ 11 per share

Tata Chemicals Limited today declared its financial results for the quarter and year ended March 31, 2026.

Commenting on the results, R. Mukundan, Managing Director & CEO, Tata Chemicals Limited, said, "During Q4FY26 the global soda ash markets remained adequately supplied and the supply overhang continue to exert pressure on pricing. The challenging external environment amid ongoing geopolitical tensions in the Middle East led to uncertainty and limited visibility on any immediate change in market conditions.

Despite the challenging external environment, the Company's standalone performance has been supported by higher volumes and disciplined cost management, resulting in a resilient operating performance. Mithapur facility (India) achieved production of 1 MTPA of Soda Ash during FY26. However, the Company's consolidated performance has been sharply impacted by continuing unsustainable unremunerative prices across geographies particularly in Southeast Asia. In US, impairment charge of ₹ 1,837 Cr of goodwill & ₹ 182 Cr of deferred tax assets write-off recognized amidst the current soda ash export market conditions.

We successfully completed the acquisition of Novabay Pte. Limited, Singapore during the quarter, as announced earlier. This acquisition aligns with our strategy of expanding high-margin specialty chemicals and strengthening our presence in key global markets. It enhances our ability to offer differentiated, value-added solutions and supports our long-term growth agenda.

The Board also approved a ₹100 crore investment to debottleneck salt capacity at our Mithapur plant by 82,500 TPA. This will strengthen our core consumer products portfolio and support long-term, sustainable growth while meeting rising demand for high-quality iodised salt.

In the midst of a challenging and volatile operating environment, our focus remains resolutely on safeguarding margins, preserving cash flows, and maintaining a strong and resilient balance sheet. We are navigating this phase with prudence and disciplined capital deployment. These actions are aimed at reinforcing the Company's financial strength and positioning us to emerge from the current cycle with sustained stability and long-term value creation for our investors.

Consolidated Highlights Q4 FY26

• Revenue from operations at ₹ 3,438 Cr, down by 2% compared to Q4FY25, driven by lower realization (mainly due to lower exports from US), offset by higher volumes in India.
• EBITDA at ₹ 274 Cr as compared to ₹ 327 Cr in Q4FY25, mainly on account of subdued pricing across all geographies and increase in fixed cost (also due to steep depreciation of Indian Rupee) as compared to Q4FY25.
• An exceptional charge of ₹ 1,837 Cr is provided on account of impairment of goodwill in US & ₹159 Cr of deferred tax assets write off.
• Profit After Tax (before exceptional items and NCI) at ₹ (279) Cr compared to ₹ (12) Cr for Q4FY25.
• Net debt (without leases) as on March 31, 2026, stood at ₹ 5,961 Cr.
• 50 kT Electric calciner soda ash plant in Kenya was operationalized.
• Acquisition of Novabay Pte. Limited, Singapore completed on 19th March 2026.

Standalone Highlights Q4 FY26

• Revenue from operations stood at ₹ 1,254 Cr, up by 3% compared to Q4FY25 due to higher volumes.
• EBITDA at ₹ 216 Cr, down by 6% compared to Q4FY25, lower realization and increase in fixed costs.
• Profit After Tax from continuing operations was ₹ 48 Cr, down by 51% compared to Q4FY25.
• Mithapur Gujarat facility achieved production of 1 MTPA of Soda Ash in FY26.

Consolidated Highlights FY26

• Revenue from operations at ₹ 14,584 Cr, down by 2% compared to FY25, due to pricing pressure in all regions and lower volumes except India & Kenya.
• EBITDA at ₹ 1,805 Cr as compared to ₹ 1,953 Cr in FY25, on account of lower realization but supported by lower fixed cost (despite steep depreciation of Indian Rupee) including due to cessation of Lostock operations in UK.
• An exceptional charge of ₹ 1,956 Cr is provided on account of impairment of goodwill in US, impact of labour code in India and costs on account of UK Soda ash plant.
• ₹ 182 Cr of deferred tax assets write off in US.
• Profit After Tax (before exceptional items and NCI) at ₹ 241 Cr compared to ₹ 479 Cr for FY25.
• Non-Soda Ash revenue grown by 14% over FY25 in line with Company's focus to grow non-cyclical business.
• During the year, Pearl Silica facility with a capacity of 3,000 MTPA at Cuddalore, Tamil Nadu, and FOS L55 facility with a capacity of 4,500 MTPA at Mambattu were commissioned.
• 5 MW solar plant, Solar Pond and 50 kT Electric calciner soda ash plant in Kenya was operationalized.

Standalone Highlights FY26

• Revenue from operations stood at ₹ 4,831 Cr, up by 9% compared to FY25 due to higher volumes, however realisations impacted due to pricing conditions in markets.
• EBITDA at ₹ 954 Cr, up by 17% compared to FY25, effect of higher volumes and cost control measures taken.
• Profit After Tax (before exceptional items) from continuing operations was ₹ 620 Cr, up by 18% compared to FY25.

About Tata Chemicals Ltd.

A part of over US$ 180 billion Tata Group, Tata Chemicals Limited, is a leading supplier of choice to Glass, Detergent, Industrial and Chemical sectors. The company has a strong position in the crop protection business through its subsidiary company, Rallis India Limited. Tata Chemicals has world class R&D facilities in Pune and Bangalore.
Website: https://www.tatachemicals.com

Statement of Consolidated Financial Results for the quarter and year ended 31 March, 2026

Particulars	Quarter ended 31 Mar 2026 (Audited)	Quarter ended 31 Dec 2025 (Unaudited)	Quarter ended 31 Mar 2025 (Audited)	Year ended 31 Mar 2026 (Audited)	Year ended 31 Mar 2025 (Audited)
a) Revenue from operations	3,438	3,550	3,509	14,584	14,887
b) Other income	44	38	42	316	225
Total income (1a + 1b)	3,482	3,588	3,551	14,900	15,112

Tata Chemicals Limited Consolidated Segment wise Revenue, Results, Assets and Liabilities
a. Basic chemistry products	2,933	2,887	3,037	11,521	12,080
b. Specialty products	505	667	472	3,076	2,815

Particulars	As at 31 Mar 2026	As at 31 Mar 2025
Property, plant and equipment	9,920	8,073
Capital work-in-progress	1,014	1,879

Sr.No.	Particulars	Q4FY26	Q3FY26	Q4FY25	FY26	FY25
1	Operating Margin (%)	(2.01%)	1.46%	0.97%	4.14%	5.58%

Tata Chemicals’ Mithapur Facility Achieves 1 Million Tonnes Soda Ash Production Milestone in FY 2025–26

Tata Chemicals Limited today announced a key operational milestone, with its Mithapur facility in Gujarat reaching 1 million tonnes of soda ash production in FY 2025–26.

Soda ash is the common name for sodium carbonate (Na₂CO₃), a white, odorless, alkaline powder widely used in glass, detergents, chemicals, and textiles. 

This milestone reflects the consistent efforts and strong collaboration across teams, including operations, maintenance, utilities, logistics, procurement, quality, safety, and other support functions. The contribution of the Marketing & Sales teams has also been instrumental in enabling this achievement.

To mark the occasion, employees at the Mithapur site came together, with senior leadership inaugurating a commemorative plaque and unveiling the miniature of one-millionth tonne bag of soda ash. The event served as a lasting reminder of the team’s commitment to operational excellence.

Rino Raj, Vice President and Site Head – Mithapur, Tata Chemicals Limited, said, "Reaching the 1 million tonne milestone is a direct outcome of the operational rigour and commitment demonstrated by our teams on the ground. From plant efficiency to reliability and safety, every function has contributed to ensuring consistent performance. This achievement belongs to the people at Mithapur who deliver excellence every single day."

Nandakumar S Tirumalai, Chief Financial Officer, Tata Chemicals Limited, added: "From a financial standpoint, this milestone reflects disciplined execution and a strong focus on cost optimisation and asset productivity. Sustained improvements in operational efficiency enable us to enhance margins while maintaining resilience in a competitive environment, supporting long-term value creation for our stakeholders."

This achievement further strengthens Tata Chemicals’ position in the global soda ash industry and underlines its focus on efficiency, reliability, and sustainable operations.

About Tata Chemicals Ltd.

A part of over US$ 180 billion Tata Group, Tata Chemicals Limited, is a leading supplier of choice to Glass, Detergent, Industrial and Chemical sectors. The company has a strong position in the crop protection business through its subsidiary company, Rallis India Limited. Tata Chemicals has world class R&D facilities in Pune and Bangalore.

Website: https://www.tatachemicals.com/

Tata Chemicals Launches ChemForce™, a Salesforce-Powered CRM to Transform Customer Experience

Tata Chemicals Limited today announced the launch of ChemForce™, a new Customer Relationship Management (CRM) platform designed to transform the way the company engages with customers and manages relationships across India. ChemForce™, powered by Salesforce Manufacturing Cloud, brings together sales and customer data on a unified platform to enhance transparency, responsiveness, and efficiency, while empowering sales teams to focus on delivering greater customer value.

The launch marks a significant milestone in Tata Chemicals’ digital journey, aimed at strengthen customer relationships by helping to ensure every interaction is consistent, responsive, and fully tracked. By creating a single source of sales and customer data, the company will drive more transparency and efficiency worldwide, freeing up sales teams to focus on customer value rather than manual processes.

Salesforce Manufacturing Cloud is set to modernize Tata Chemicals' operations, offering a specialized solution for the industry's unique needs. By leveraging contextualized data, AI, and analytics across the entire value chain, Tata Chemicals can deliver a distinctive experience to its customers and distributors, supported by valuable insights.

Comments on the News

Commenting about the initiative, Mr Subodh Srivastav, CMO, Tata Chemicals, said, “With this launch, Tata Chemicals is taking a strategic leap forward in our digital transformation journey. By integrating comprehensive customer and sales data onto a unified platform, we will enhance our ability to deliver consistent, timely, and personalised engagement. This will be crucial in driving sustainable growth by enabling data-driven decision-making and fostering stronger customer relationships across our global operations.”

Vikrant Deoras, Chief Information & Digital Officer, Tata Chemicals, said: “The launch represents a crucial step in our digital transformation journey. By implementing core enterprise applications such as this, we are not only enhancing transparency and consistency in customer engagement today but also building a strong digital backbone for tomorrow. It will enable us to harness the power of data and AI, driving smarter decisions and creating a truly connected, customer-centric organisation.”

Mankiran Chowhan, Managing Director - Sales, Salesforce India, said, “Our partnership with an industry pioneer like Tata Chemicals goes beyond technology; it's about co-creating the future of customer and distributor engagement. Tata Chemicals is building a truly connected ecosystem, turning every interaction from a simple transaction into an intelligent and distinctive experience with Salesforce’s AI-driven platform. This deepens relationships across their entire value chain and sets a new benchmark for excellence, turning their network into a powerful engine for sustainable growth."

Manu Singla, Partner, Deloitte India, also said about the initiative that, “We are proud to partner with Tata Chemicals on the design and implementation of ChemForce™, a platform that reimagines how customer relationships are built and sustained in a digital-first world. It directly addresses the challenges of fragmented customer data and manual sales processes by enhancing transparency and decision-making, and empowering sales teams to deliver greater customer value. This collaboration reflects Deloitte’s commitment to enabling large enterprises to embed digitization at the core of their business, laying the foundation for future innovations including AI-driven customer insights and personalization at scale.”

The new platform will significantly improve customer experience by enabling faster responses, better follow-ups, and a personalized engagement journey. It will boost sales processes, allowing for smarter and quicker decision-making. The platform will empower teams with real-time data, actionable insights, and seamless collaboration across functions and regions. By creating a single source of truth for customer and sales information, thereby reducing duplication and increasing operational efficiency.

ChemForce™ will be used by Tata Chemicals’ sales teams across its operations in India. Over time, the platform will also evolve to integrate with other functions as well as customers and distributors, further strengthening customer centricity.

Tata Chemicals and BSDT’s Integrated Cancer Treatment and Research Centre (ICTRC), Pune Ink MoU to Bridge Modern Scientific Research with Traditional Ayurvedic Wisdom

Tata Chemicals Limited (TCL) a leading sustainable and science-led chemistry solutions company has signed a Memorandum of Understanding (MoU) with Bharatiya Sanskriti Darshan Trust (BSDT) – BSDT’s Integrated Cancer Treatment and Research Centre (ICTRC) in Pune. This collaboration aims to explore the beneficial effects of TCL's prebiotic, soluble dietary fibers, and their derivatives on gut health and overall wellness. This initiative underscores Tata Chemicals' and BSDT's shared commitment to delivering science-backed nutrition solutions that enhance quality of life.

The MoU was signed in the presence of Tata Chemicals' R&D team, led by Dr. Richard Lobo, and the BSDT team, led by Dr. Sushrut S. Sardeshmukh, Trustee, BSDT, and Dr. Vineeta V. Deshmukh, Deputy Director, ICTRC. This partnership will focus on integrating scientific research with Ayurvedic principles to develop advanced solutions for health and wellness.

Speaking on the occasion of signing the MoU, Dr. Richard Lobo – Head - Innovation, R&D, Business Excellence and Chief Ethics Counsellor at Tata Chemicals said "This is a momentous occasion for us as BSDT’s Integrated Cancer Treatment and Research centre's mission and its values are closely aligned with that of Tata Chemicals. We are committed to working together in understanding and improving the functionality of our science-differentiated products in Ayurvedic formulations, for improving the quality of life & alleviating pain through Ayurvedic disciplines.”

Dr. Sushrut S. Sardeshmukh, Trustee at Bharatiya Sanskriti Darshan Trust added “We are very pleased to be working closely with Tata Chemicals. At BSDT, our mission has always been to integrate Ayurveda with modern science to enhance patient care and improve quality of life. This collaboration is a significant step towards advancing research in Ayurveda integrated in wellness products with science-backed innovations. By combining our expertise in holistic healing with Tata Chemicals’ commitment to Innovative products, we aim to further explore solutions that support holistic well-being.”

BSDT, through its expertise in Ayurveda, has been instrumental in improving the quality of life and alleviating cancer-related suffering for thousands of patients. By combining Tata Chemicals’ nature-driven innovations with BSDT’s traditional healing approach, this initiative aims to advance nutritional science, expand the scope of holistic wellness, and develop impactful solutions that bridge tradition and modern healthcare advancements